Skip to main content
. Author manuscript; available in PMC: 2016 Apr 14.
Published in final edited form as: Leuk Lymphoma. 2015 Mar 8;56(9):2643–2649. doi: 10.3109/10428194.2015.1011156

Table II.

Multivariate Survival Analysis (WUSM)

95.0% CI for HR

HR1 Lower Upper p value
SES 0.022
 High-SES 12
 Middle-SES 1.25 0.95 1.65 0.114
 Low-SES 1.54 1.13 2.09 0.006
Age (per year) 1.02 1.01 1.04 0.002
Year of Diagnosis (per year) 0.95 0.91 0.99 0.031
Race <0.001
 White 12
 Black 0.57 0.42 0.76 0.001
 Other 1.97 0.92 4.24 0.083
Comorbidity Score 0.002
 None 12
 Mild 1.12 0.85 1.47 0.433
 Moderate 1.34 0.97 1.84 0.074
 Severe 2.17 1.43 3.28 <0.001
SCT Utilization <0.001
 Yes 12
 No 2.57 1.96 3.38 <0.001
Insurance Provider 0.058
 Private 12
 Medicare 0.74 0.53 1.03 .071
 Medicaid 1.224 0.70 2.14 .478
 No Insurance 1.59 0.94 2.70 .083
1

Controlled for all other variables within the model

2

Reference level